Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Wilson Therapeutics AB

Closing information (x1000 SEK)

Closing information 2020/12 2019/12 2018/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 880,970 Less Arrow 2,264 More Arrow 3,370
Earnings before taxes -677,694 More Arrow 6,739,083 Less Arrow -391,134
EBITDA -836 More Arrow 6,658,259 Less Arrow -402,090
Total assets 6,441,615 More Arrow 13,012,861 Less Arrow 80,731
Current assets 6,441,515 More Arrow 13,011,394 Less Arrow 14,308
Current liabilities 67,056 More Arrow 5,960,608 Less Arrow 44,660
Equity capital 6,374,559 More Arrow 7,052,253 Less Arrow 35,939
- share capital 3,144 Equal arrow 3,144 Equal arrow 3,144
Employees (average) 0 More Arrow 1 More Arrow 14

Financial ratios

Fiscal year 2020/12 2019/12 2018/12
Solvency 99.0% Less Arrow 54.2% Less Arrow 44.5%
Turnover per employee 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) 3.2% More Arrow 51.8% Less Arrow -480.3%
Current ratio 9606.2% Less Arrow 218.3% Less Arrow 32.0%
Return on equity (ROE) -10.6% More Arrow 95.6% Less Arrow -1088.3%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -1 Less Arrow -13 More Arrow 0
Chg. No. of employees % -100% More Arrow -93%

Total value of public sale

Fiscal year 2020/12 2019/12 2018/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.